Adapting social media to the business world obviously requires more than just tweaking the Facebook or Match.com models. The belief that a well-constructed social media platform can be an effective business tool for the device industry fired the imagination of Peter von Dyck. In this MX interview, von Dyck touches on topics such as the challenges in launching the online venture, the benefits and drawbacks of using social media as a business tool, navigating "the paranoia element" of the device industry, and the familial origins of the company’s name.
Anaheim, CA, US
Good Monitoring Practices Workshop
SPIE Medical Imaging
San Diego, CA, US
Medical Devices: Demystifying Regulation and Guidance
Arlington, VA, US
Venture Capital Resources
More from This Issue
Responding to a Cease-And-Desist Letter
The medical device industry is one of the more litigious when it comes to patents. The legal scenario described next is all too common. A competitor sends you a letter asserting that your company’s new medical breakthrough device infringes its patent. More often than not, the letter demands that you cease making and selling the product in question under a threat of patent litigation if you do not comply. Immediately. Patent attorney James Juo gives advice on how to respond to a cease-and-desist letter.
A Seat at the Strategy Table
Amid the ebb and flow of our national debate over healthcare reform there is one certainty: The business of making and selling healthcare products as we have known it is a thing of the past. Several signs already show us that the old formulas for success aren’t going to work that well anymore. Rita Numerof and Bill Ott discuss strategies that can help medical device manufacturers compete in the new market environment.
Molecular Biometrics Inc., a metabolomics company developing clinical diagnostic tools for personalized medicine, announced that it has completed a $12.5 million Series B financing. Read more.
A growth investor has purchased a majority share in TNI Medical AG (Freiburg and Würzburg, Germany), a medical firm specializing in sleep-breathing technologies. Read more.
Candela Corp. and Syneron Medical Ltd. have merged in an all-stock transaction, following a shareholder vote on January 5, 2010. Read more.